S-3 GROUP

Lobbying for ACTUM OBO ILLUMINA, INC. · Biotechnology company

Filing 3rd Quarter - Termination

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Jan 13, 2026

Lobbying activity 3

Health Issues

Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies.

Taxation/Internal Revenue Code

Issues and legislation related to tax reform and corporate tax policy

Trade (domestic/foreign)

General discussion and monitoring of U.S. trade policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.